- Home
- VRAX vs MEGL Comparison
VRAX vs MEGL Comparison
Compare VRAX & MEGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VRAX | MEGL |
|---|---|---|
| Founded | 2013 | 2016 |
| Country | United Kingdom | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9M | 6.6M |
| IPO Year | 2022 | 2022 |
Fundamental Metrics
Financial Performance| Metric | VRAX | MEGL |
|---|---|---|
| Price | $0.41 | $1.22 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 570.8K | 28.3K |
| Earning Date | 01-01-0001 | 12-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,986.00 | ★ $1,296,394.00 |
| Revenue This Year | $217,274.83 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.31 | $1.02 |
| 52 Week High | $3.20 | $5.52 |
Technical Indicators
Market Signals| Indicator | VRAX | MEGL |
|---|---|---|
| Relative Strength Index (RSI) | 49.47 | 46.38 |
| Support Level | $0.33 | $1.18 |
| Resistance Level | $0.44 | $1.25 |
| Average True Range (ATR) | 0.04 | 0.04 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 50.33 | 50.99 |
Price Performance
Historical ComparisonAbout VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes (HSV-1) and Human Papillomavirus (HPV).
About MEGL Magic Empire Global Limited
Magic Empire Global Ltd is a financial services provider in Hong Kong which principally engage in the provision of corporate finance advisory services and underwriting services. The companys offerings mainly comprise of IPO sponsorship services, Financial advisory and independent financial advisory services, Compliance advisory services, Underwriting services, Corporate service.